Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Merck Frosst launches Varivax II for protection against chickenpox

June 23, 2000

Meningococcal C conjugate vaccine shown to be safe and immunogenic in infants

June 23, 2000

Licensing opportunity from NIH: polypeptides interacting with formyl peptide receptors

June 22, 2000

BioChem Pharma and Cytovax sign collaborative agreement

June 21, 2000

Immunosuppressive 2-acylquinolines developed by Japanese lab

June 19, 2000

Nexell obtains exclusive license to Diaclone antibody portfolio

June 19, 2000

Chiron and Norwegian National Institutes of Public Health formalize meningitis agreement

June 19, 2000

Synthetic peptide enhances the microbicidal activity of monocytes

June 16, 2000

Phase I clinical trial begins for Cantab's cervical dysplasia vaccine

June 16, 2000

AdProTech enters collaboration with PowderJect for DNA vaccine program

June 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...